Skip to main content
OpenTrials
Completed

NCT Number: NCT05651581

Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities

The study team will create an online module via the REDCap platform. The module will include around 5 videos and several infographics covering the topics of symptoms, transmission, prevention, vaccination, and treatment of the monkeypox virus. Surveys assessing the primary and secondary study endpoints will be given to participants before and after the module. The purpose of the study is to assess the efficacy and acceptability of an educational presentation on monkeypox in a cohort of individuals recruited from Rainbow Health and to secondarily assess participant risk perception, intention to vaccinate, and confidence in public health initiatives.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Monkey Pox Animal Diseases DNA Virus Infections Infections Mpox, Monkeypox Poxviridae Infections Primate Diseases Rodent Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals who are 18 years and older
  • Individuals able to read and write in English

Exclusion criteria

  • Unable to provide informed consent

Treatment and study plan

Online module

Other

online module including around 5 videos and several infographics covering the topics of symptoms transmission, prevention, vaccination, and treatment of the monkeypox virus.

Primary outcomes

  1. Efficacy of intervention

    Time frame: baseline

    Efficacy of intervention will be measured by changes in knowledge using a survey

  2. Efficacy of intervention

    Time frame: immediately after intervention

    Efficacy of intervention will be measured by changes in knowledge using a survey

  3. Acceptability

    Time frame: immediately after intervention

    Acceptability will be measured by a validated questionnaire based on the Theoretical Framework of Acceptability.

Secondary outcomes

  1. risk perception

    Time frame: baseline

    questionnaire

  2. risk perception

    Time frame: immediately after intervention

    questionnaire

  3. intention to vaccinate

    Time frame: baseline

    questionnaire

  4. intention to vaccinate

    Time frame: immediately after intervention

    questionnaire

  5. confidence in public health initiatives

    Time frame: baseline

    questionnaire

  6. confidence in public health initiatives

    Time frame: immediately after intervention

    questionnaire

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Dec 15, 2022
Registry last updated
Oct 4, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.